MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
100.44
-0.53
-0.52%
After Hours: 100.30 -0.14 -0.14% 19:30 09/08 EDT
OPEN
100.85
PREV CLOSE
100.97
HIGH
100.94
LOW
100.37
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
111.86
52 WEEK LOW
49.67
MARKET CAP
6.56B
P/E (TTM)
24.30
1D
5D
1M
3M
1Y
5Y
1D
Lantheus Sets October Vote on Curium Buyout With Cash and CVR Package
TipRanks · 14h ago
Weekly Report: what happened at LNTH last week (0831-0904)?
Weekly Report · 1d ago
Weekly Report: what happened at LNTH last week (0824-0828)?
Weekly Report · 08/31 09:30
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Barchart · 08/29 06:41
Avantis U.S. Small Cap Value ETF Experiences Big Outflow
NASDAQ · 08/28 14:56
The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
Seeking Alpha · 08/25 03:11
Weekly Report: what happened at LNTH last week (0817-0821)?
Weekly Report · 08/24 09:30
Noteworthy ETF Inflows: AVUV, MATX, LNTH, VSAT
NASDAQ · 08/20 14:47
More
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. Its product categories include oncology, neurology, cardiology, and strategic partnerships and others. Its products include PYLARIFY, Neuraceq, and DEFINITY. PYLARIFY TruVu is indicated for PET imaging of PSMA-positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy, or suspected recurrence based on elevated serum prostate-specific antigen (PSA). Neuraceq is an Alzheimer's disease radiodiagnostic. Its commercial products are used by cardiologists, internists, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists across a range of clinical care settings. Its diagnostic products provide information that enables healthcare professionals (HCPs) to better detect, characterize, or rule out diseases.

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.